【Altek Chemical Pharmaceutical Co., Ltd.】2026 Q1 EPS 2.18 Yuan

Company Code: 1795
Company Name: Altek Chemical Pharmaceutical Co., Ltd.
Industry: Biotech and Pharmaceutical Industry
Fiscal Year/Quarter: 2026 Q1
Basic Earnings Per Share: 2.18 Yuan
Operating Revenue: 8.644 billion Yuan
Net Profit After Tax: 567 million Yuan

Keywords: Financial Report, Biotech and Pharmaceutical Industry, EPS

Analysis and Translation:

This press release from Altek Chemical Pharmaceutical Co., Ltd. presents its financial results for the first quarter of 2026. The company reported a basic Earnings Per Share (EPS) of 2.18 Yuan. Its operating revenue for the quarter reached 8.644 billion Yuan, with a net profit after tax of 567 million Yuan. This report provides key financial performance data for the company in the biotech and pharmaceutical industry, demonstrating its strong profitability.

layer1_extraction:
summary: "Altek Chemical Pharmaceutical Co., Ltd. (1795) announced its Q1 2026 Earnings Per Share (EPS) of 2.18 Yuan, with operating revenue of 8.644 billion Yuan and net profit after tax of 567 million Yuan. This financial report highlights the company's strong profitability in the biotech and pharmaceutical industry."
detailed_summary: "Altek Chemical Pharmaceutical Co., Ltd. (1795) has released its financial report for the first quarter of 2026, showing a basic Earnings Per Share (EPS) of 2.18 Yuan. During the same period, operating revenue reached 8.644 billion Yuan, with a net profit after tax of 567 million Yuan. This report provides key financial performance data for the company in the biotech and pharmaceutical industry sector, demonstrating its robust profitability."
news_type: "Financial Report"
urgency: "Near-term"
industries: ["Biotech and Pharmaceutical Industry"]
b2b_or_b2c: "B2B"
products_services: ["Pharmaceuticals", "Medical Devices"]
companies_mentioned: []
people_mentioned: []
amounts: ["EPS 2.18 Yuan", "Operating Revenue 8.644 billion Yuan", "Net Profit After Tax 567 million Yuan"]
dates_mentioned: ["2026 Q1"]
locations: []
technologies: []
target_audience: "Investors, Industry Analysts"
geographic_scope: "International"
media_assets: "None"

layer2_reasoning:
en:
what_it_means: "Biotech pharmaceutical company Altek's Q1 financial report shows strong performance with an EPS of 2.18 Yuan."
company_strategy_signal: "The company is likely benefiting from successful new drug development or market expansion, indicating strong growth momentum and market leadership."
industry_implication: "The Q1 performance in the biotech and pharmaceutical industry was robust. Altek's high EPS marks it as a leader in the sector, potentially boosting investment interest in related fields."
competitive_landscape: "In the highly competitive biotech and pharmaceutical market, Altek's strong financial results show its ability to effectively navigate challenges and potentially expand its market share."
market_signal: "The market maintains an optimistic outlook on the long-term growth prospects of the biotech and pharmaceutical industry, and this report confirms the sector's investment value."
prediction: "It is expected that Altek will continue its strong growth trend in the next two quarters, with EPS likely to remain above 2 Yuan. New R&D projects or expansion plans may also be announced."
related_trends: ["Breakthroughs in new drug development", "Increasing global healthcare demand"]
investment_signal: "High EPS and stable revenue growth indicate a high-growth stock, suitable for growth-oriented investors."
risk_factors: ["Risk of new drug development failure", "Regulatory review changes", "Impact of patent expirations"]
opportunity_for_us: "Conduct an in-depth analysis of its new drug R&D pipeline and market strategy to identify potential collaboration or investment opportunities."

company_business: "Biotech and pharmaceutical manufacturing and sales."
company_profile:
official_url: ""
address: ""
established: ""
capital: ""
employees: ""
ceo: ""
business_description: ""
image_description:
what_is_shown: "No image is present in the provided article data."
alt_ja: "記事本文には画像は含まれていません。"
alt_en: "No image is included in the article text."
alt_zh: "文章內不含圖片。"